As of 2024-07-27, the EV/EBITDA ratio of Infinity Pharmaceuticals Inc (INFI) is 0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INFI's latest enterprise value is -16.29 mil USD. INFI's TTM EBITDA according to its financial statements is -41.62 mil USD. Dividing these 2 quantities gives us the above INFI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 21.5x | 16.6x |
| Forward P/E multiples | 17.8x - 24.1x | 21.4x |
| Fair Price | (22.26) - (27.00) | (23.79) |
| Upside | -49891.0% - -60494.9% | -53330.1% |
| Date | EV/EBITDA |